8123 Roper Road NW
OncoQuest Inc. (“OncoQuest”) is a Canadian biotechnology company, developing and commercializing products for the treatment of cancer. OncoQuest is a clinical stage company, focused on combinatorial immunotherapeutic approaches to cancer by using either immunoglobulin G or E (IgG or IgE) and chemotherapy or immune-adjuvant or photodynamic therapy to enhance tumor specific immunity and clinical outcomes.
CEO: Dr. Ragupathy ‘Madi’ Madiyalakan, Ph.D.
VP, Product Development: Thomas Woo, M.Sc.
CFO: Pierre Vermette, C.P.A.
Please click here for Oncoquest's pipeline.